Simplex Trading’s Y-mAbs Therapeutics YMAB Stock Holding History

Simplex Trading’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,600	Closed	-$43K	–	10243
2025 Q2	$43K	Buy	+9,600	New	+$43.1K	﹤0.01%	6085
2025 Q1	–	Sell	-200	Closed	-$1K	–	9870
2024 Q4	$1K	Sell	200 -2,000	-91%	-$24.4K	﹤0.01%	8343
2024 Q3	$28K	Buy	2,200 +1,100	+100%	+$13.9K	﹤0.01%	6419
2024 Q2	$13K	Sell	1,100 -700	-39%	-$9.45K	﹤0.01%	7272
2024 Q1	$29K	Buy	1,800 +900	+100%	+$12.1K	﹤0.01%	6792
2023 Q4	$6K	Buy	+900	New	+$5.21K	﹤0.01%	7801
2023 Q2	–	Sell	-700	Closed	-$3K	–	10109
2023 Q1	$3K	Sell	700 -2,900	-81%	-$11.8K	﹤0.01%	8372
2022 Q4	$17K	Sell	3,600 -9,200	-72%	-$66.8K	﹤0.01%	7054
2022 Q3	$184K	Sell	12,800 -500	-4%	-$8.28K	﹤0.01%	4730
2022 Q2	$201K	Buy	13,300 +700	+6%	+$8.17K	﹤0.01%	4592
2022 Q1	$149K	Buy	+12,600	New	+$129K	﹤0.01%	5598

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Simplex Trading's YMAB Position: Q2 2025 in Review

Simplex Trading sold out of Y-mAbs Therapeutics (YMAB) in Q2 2025, closing a stake of 437 shares — an estimated $1.96K sold.

Simplex Trading first reported a position in YMAB in Q4 2020 and held it in 10 quarters. The position peaked at $27K in Q3 2022. 97 funds tracked by Wall St. Rank hold YMAB as of Q2 2025.

Simplex Trading reported no remaining Y-mAbs Therapeutics position as of Q2 2025 after selling out during the quarter.
Simplex Trading sold 437 Y-mAbs Therapeutics shares in Q2 2025, an estimated $1.96K.
Simplex Trading first reported a position in Y-mAbs Therapeutics in Q4 2020 and held it in 10 quarters.
Simplex Trading's Y-mAbs Therapeutics position peaked at $27K in Q3 2022.
97 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.